ExploreWatchlistsPricing
  1. JP-listed companies
  2. Nissui Pharmaceutical Co., Ltd.
  3. Financials
  4. Revenue

Nissui Pharmaceutical Co., Ltd. (E00971)

Market cap
P/E ratio
Nissui Pharmaceutical manufactures and sells diagnostic drugs, test reagents, and testing equipment to medical institutions and testing facilities.
SummaryFinancialsDividendsHistoryWorkforce
Period EndRevenue (Million JPY)YoY (%)
Mar 31, 202216,657+34.50%
Mar 31, 202112,384-3.05%
Mar 31, 202012,773+1.79%
Mar 31, 201912,549+1.78%
Mar 31, 201812,329-3.87%
Mar 31, 201712,825+6.74%
Mar 31, 201612,015+1.28%
Mar 31, 201511,863-9.72%
Mar 31, 201413,141-0.37%
Mar 31, 201313,190-1.49%
Mar 31, 201213,389

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat